PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells

Jia-Yu Tan1, Xiang Huang, Ya-Ling Luo

  • 1Intensive Care Unit, Bo'ai Hospital Affiliated with Southern Medical University, Zhongshan 528403, China.

Insights

Proteasome subunit alpha type-7 (PSMA7) inhibits lung adenocarcinoma cell proliferation and invasion. This suggests PSMA7 is a potential tumor biomarker for A549 cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The gene for proteasome subunit alpha type-7 (PSMA7) is located in chromosomal region 20q13.33.
  • This chromosomal region is frequently amplified in various tumors.

Purpose of the Study:

  • To investigate the role of PSMA7 in the proliferation, tumorigenicity, and invasion of A549 human lung adenocarcinoma cells.
  • To determine if PSMA7 can serve as a potential tumor biomarker.

Main Methods:

  • Utilized A549 human lung adenocarcinoma cells for in vitro experiments.
  • Conducted gain and loss of function studies.
  • Employed a xenograft nude mice model to assess tumorigenicity in vivo.

Main Results:

  • PSMA7 was found to inhibit the proliferation, tumorigenicity, and invasion of A549 cells in vitro.
  • Gain and loss of function studies confirmed that PSMA7 modulates the tumorigenicity of A549 cells in a xenograft nude mice model.

Conclusions:

  • PSMA7 exhibits inhibitory effects on the tumorigenicity of A549 lung adenocarcinoma cells.
  • PSMA7 is identified as a potential tumor biomarker for lung adenocarcinoma.